aXichem AB (publ), announces that the company has entered into an agreement with Västra Hamnen Corporate Finance AB regarding the position as Certified Adviser, starting on January 2, 2023.
This information was published by the contact person below on 30 November 2022, 09:50 AM CET.
Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: firstname.lastname@example.org
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a natural analogue synthetic capsaicin with a wide range of applications, such as nutraceuticals, feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB. Read more about aXichem at www.axichem.se